from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3097c/lipY

LFCtreatmentdescriptionclass of inhibitor

1.172

Amikacinug/mL Amikacintranslation

1.179

Cap5-10ug/mL Capreomycintranslation

1.269

Rox10-50 ug/mL Roxithromycintranslation

-0.202

SM2-5 ug/mL Streptomycintranslation

1.177

Tet5-10 ug/mL Tetracyclinetranslation

1.037

Rif0.2-5ug/mL Rifampicintranscription

1.928

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.629

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.468

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.283

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.013

Clofazimine10-13 ug/mL Clofaziminerespiration

0.567

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.441

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.186

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.468

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.448

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.631

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.444

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.259

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.560

KCN5-20 ug/mL Potassium cyaniderespiration

0.511

NaN30.2-2 mM Sodium aziderespiration

-0.536

Nigericin50 uM Nigericinrespiration

0.236

TRC10-150 ug/mL Triclosanrespiration

0.776

TRZ10-25 ug/mL Thioridazinerespiration

-0.057

Valinomycin0.5-10 uM Valinomycinrespiration

-0.526

ZnSO42 mM ZnSO4respiration

-0.840

menadione6-10 ug/mL Menadionerespiration

-0.075

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.558

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.068

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.309

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.038

NRP_1Non-replicating persistence stage 1dosRassociated

-0.668

Amp0.2mg/mL AmpicillincellWall

-0.150

Cephalexin20-100 ug/mL CephalexincellWall

0.362

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.881

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.439

EMB10-20 ug/mL EthambutolcellWall

-0.081

Eta12-40 ug/mL EthionamidecellWall

0.141

INH0.2-0.4 ug/mL IsoniazidcellWall

0.135

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.190

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.011

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.594

BZA0.12 mg/mL BenzamidearomaticAmides

-0.523

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.535

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.290

H2O24 mM hydrogen peroxideDNAdamaging

1.312

Levo10 ug/mL LevofloxacinDNAdamaging

-0.873

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.342

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.248

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.318

UVUV-irradiationDNAdamaging

1.271

ARP41-4 ug/mL Antitubercular compound ARP4?

1.005

Antimycin12.5-50 ug/mL Antimycin A?

-0.326

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.433

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.325

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.657

PA8240.2-2 ug/mL PA-824?

0.598

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.492

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.575

Verapamil50 uM Verapamil?

0.735

mercaptoethanol2 mM 2-Mercaptoethanol?

0.362

methoxatin10-20 ug/mL Methoxatin?